Concert AI

ConcertAI | Leaders in Generative & Agentic AI Solutions Tailored for Life Sciences & Healthcare

Boston, United States · Founded 2018 · $300.0M raised

Employees
1001–5000
Founded
2018
Business Model
B2B
Total Funding
$300.0M
Last Round
$150.0M Series CMar 2022
Rounds
2

About

ConcertAI is the leader in predictive and generative AI SaaS and real-world data solutions for healthcare and life sciences. The company accelerates insights and outcomes for patients through research-ready data, CARAai technologies, and scientific expertise, partnering with over 46 biomedical innovators, 2,000 healthcare providers, and medical societies. Headquartered in Cambridge, MA, ConcertAI also operates TeraRecon for radiological imaging AI and CancerLinQ for oncology quality solutions.

Summary

Concert AI is an Artificial Intelligence company based in Boston, United States, founded in 2018. It has raised $300.0M in total across 2 rounds, most recently a $150.0M Series C round in Mar 2022. Investors include Sixth Street, Declaration Partners and Maverick Ventures.

Tech & App Stack

9 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CMar 2022
$150.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies